1Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol, 2011, 22:2675-2686.
2Isacson CK, Lu Q, Karas RH, et al. RACK1 is a BKCa channel binding protein. Am J Physiol Cell Physiol, 2007, 292: 1459- 1466.
3Berns H, Humar R, Hengerer B, et al. RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J, 2000, 14: 2549-2558.
4Mamidipudi V, Zhang J, Lee KC, et al. RACK1 regulates G1/S progression by suppressing Src kinase activity. Mol Cell Biol, 2004, 24:6788-6798.
5Ron D, Chen CH, Caldwell J, et al. Cloning of an intraeellular receptor for protein kinase C : a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A, 1994, 9l :839-843.
6Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical eanccr worldwide. J Pathol, 1999, 189 : 12-19.
7McCahill A, Warwicker J, Bolger GB, et al. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol Pharmacol, 2002. 62 : 1261-1273.
8Wang Z, Zhang B, Jiang L, et al. RACKI, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J Cancer, 2009, 45:490-496.
9Wang Z, Jiang L, Huang C, et al. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics, 2008, 7 : 1639-1650.
10Blake RA, Broome MA, Liu X, et al. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol, 2000, 20:9018-9027.
